Repression of the TMEFF2 promoter by c-Myc

被引:16
作者
Gery, S [1 ]
Koeffler, HP [1 ]
机构
[1] Univ Calif Los Angeles, Cedars Sinai Med Ctr, Sch Med, Div Hematol Oncol, Los Angeles, CA 90048 USA
关键词
TMEFF2; c-Myc; promoter; transcriptional-suppression; growth inhibition;
D O I
10.1016/S0022-2836(03)00404-2
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
TMEFF2 is a novel transmembrane protein, containing two follistatin domains and an epidermal growth factor-like motif that is mainly expressed in the prostate and brain. Recently, we showed that expression of TMEFF2 could inhibit prostate cancer cell growth. In addition, the TMEFF2 gene is frequently hypermethylated in human tumor cells, suggesting that it might be a tumor suppressor gene. We cloned the 5'-flanking region of the human TMEFF2 gene and using a luciferase reporter assay showed that it contains a functional promoter. The 0.7 kb region upstream to the TMEFF2 transcription start site encompasses the minimal promoter required for TMEFF2 expression. Sequence analysis of the TMEFF2 promoter revealed potential binding sites for several transcription factors including Sp1 and an E-box that could be recognized by c-Myc. An inverse correlation between TMEFF2 and c-Myc expression was found in CWR22 prostate xenografts. Reporter gene and mobility shift assays demonstrated that c-Myc could repress TMEFF2 gene expression through its cognate site. In light of the probable role of TMEFF2 in inhibiting cell growth, its suppression may contribute to the oncogenic properties of c-Myc. (C) 2003 Elsevier Science Ltd. All rights reserved.
引用
收藏
页码:977 / 983
页数:7
相关论文
共 26 条
[1]   Prostate cancer cell cycle regulators: Response to androgen withdrawal and development of androgen independence [J].
Agus, DB ;
Cordon-Cardo, C ;
Fox, W ;
Drobnjak, M ;
Koff, A ;
Golde, DW ;
Scher, HI .
JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1999, 91 (21) :1869-1876
[2]   Myc-mediated transformation: the repression connection [J].
Claassen, GF ;
Hann, SR .
ONCOGENE, 1999, 18 (19) :2925-2933
[3]  
Dang CV, 1999, MOL CELL BIOL, V19, P1
[4]   Deconstructing Myc [J].
Eisenman, RN .
GENES & DEVELOPMENT, 2001, 15 (16) :2023-2030
[5]   HUMAN EPIDERMAL GROWTH-FACTOR - DISTINCT ROLES OF TYROSINE-37 AND ARGININE-41 IN RECEPTOR-BINDING AS DETERMINED BY SITE-DIRECTED MUTAGENESIS AND NUCLEAR-MAGNETIC-RESONANCE SPECTROSCOPY [J].
ENGLER, DA ;
MONTELIONE, GT ;
NIYOGI, SK .
FEBS LETTERS, 1990, 271 (1-2) :47-50
[6]   Cdc25 cell-cycle phosphatase as a target of c-myc [J].
Galaktionov, K ;
Chen, XC ;
Beach, D .
NATURE, 1996, 382 (6591) :511-517
[7]   Myc represses the p21(WAF1/CIP1) promoter and interacts with Sp1/Sp3 [J].
Gartel, AL ;
Ye, X ;
Goufman, E ;
Shianov, P ;
Hay, N ;
Najmabadi, F ;
Tyner, AL .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2001, 98 (08) :4510-4515
[8]   TMEFF2 is an androgen-regulated gene exhibiting antiproliferative effects in prostate cancer cells [J].
Gery, S ;
Sawyers, CL ;
Agus, DB ;
Said, JW ;
Koeffler, HP .
ONCOGENE, 2002, 21 (31) :4739-4746
[9]   TENB2, a proteoglycan identified in prostate cancer that is associated with disease progression and androgen independence [J].
Glynne-Jones, E ;
Harper, ME ;
Seery, LT ;
James, R ;
Anglin, I ;
Morgan, HE ;
Taylor, KM ;
Gee, JM ;
Nicholson, RI .
INTERNATIONAL JOURNAL OF CANCER, 2001, 94 (02) :178-184
[10]   The Myc/Max/Mad network and the transcriptional control of cell behavior [J].
Grandori, C ;
Cowley, SM ;
James, LP ;
Eisenman, RN .
ANNUAL REVIEW OF CELL AND DEVELOPMENTAL BIOLOGY, 2000, 16 :653-699